Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Neuroendocrine Carcinoma

  • Ignacio Duran
  • Lillian L. Siu
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_4029-4

Synonyms

Definition

Neuroendocrine carcinomas are tumors derived from the diffuse neuroendocrine system.

Characteristics

Neuroendocrine carcinomas will include a heterogeneous group of tumors that can arise wherever the diffuse neuroendocrine system is found throughout the body.

Classification

It is widely accepted to divide these malignancies in two major groups: carcinoid tumors and neuroendocrine tumors of the pancreas. There are other, rare malignancies that also are classified as neuroendocrine carcinomas, including pheochromocytomas, medullary thyroid carcinoma, and Merkel cell tumors.

Other subclassifications will consider these tumors according to site of origin (lung, gastrointestinal tract, etc.), capability of producing certain hormones (functioning and nonfunctioning tumors), degree of cellular differentiation as an indicator of biological aggressiveness (well,...

Keywords

Neuroendocrine Tumor Carcinoid Tumor Multiple Endocrine Neoplasia Type Neuroendocrine Carcinoma Islet Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Duran I, Salazar R, Casanovas O et al (2007) New drug development in digestive neuroendocrine tumors. Ann Oncol 18(8):1307–1313CrossRefPubMedGoogle Scholar
  2. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:934–959CrossRefPubMedGoogle Scholar
  3. Oberg K (1998) Carcinoid tumors: current concepts in diagnosis and treatment. Oncologist 3:339–345Google Scholar
  4. Oberg K (2004) Management of neuroendocrine tumors. Ann Oncol 15(Suppl 4):293–298Google Scholar
  5. Robertson RG, Geiger WJ, Davis NB (2006) Carcinoid tumors. Am Fam Physician 74:429–434PubMedGoogle Scholar

See Also

  1. (2012) Antiangiogenic. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 207. doi:10.1007/978-3-642-16483-5_310Google Scholar
  2. (2012) Chemoembolization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 772. doi:10.1007/978-3-642-16483-5_1065Google Scholar
  3. (2012) Chromogranin A. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 834. doi:10.1007/978-3-642-16483-5_1135Google Scholar
  4. (2012) Diffuse Neuroendocrine System. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1116. doi:10.1007/978-3-642-16483-5_1619Google Scholar
  5. (2012) Embolization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1220. doi:10.1007/978-3-642-16483-5_1856Google Scholar
  6. (2012) Glucagonoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1558. doi:10.1007/978-3-642-16483-5_2428Google Scholar
  7. (2012) 5-HydroxyIndoleacetic Acid. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1779. doi:10.1007/978-3-642-16483-5_2892Google Scholar
  8. (2012) Interferon. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1888. doi:10.1007/978-3-642-16483-5_3090Google Scholar
  9. (2012) Medullary Thyroid Carcinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2199–2200. doi:10.1007/978-3-642-16483-5_3600Google Scholar
  10. (2012) MTOR. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2384. doi:10.1007/978-3-642-16483-5_3867Google Scholar
  11. (2012) Octreotide. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2597. doi:10.1007/978-3-642-16483-5_4190Google Scholar
  12. (2012) Palliative. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2759. doi:10.1007/978-3-642-16483-5_4350Google Scholar
  13. (2012) Somatostatinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3470. doi:10.1007/978-3-642-16483-5_5416Google Scholar
  14. (2012) Somatostatin Receptor Scintigraphy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3470. doi:10.1007/978-3-642-16483-5_5415Google Scholar
  15. (2012) Sunitinib. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3562. doi:10.1007/978-3-642-16483-5_5575Google Scholar
  16. (2012) VIPoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3908. doi:10.1007/978-3-642-16483-5_6190Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Medical Oncology and Hematology, Robert and Maggie Bras and Family New Drug Development ProgramPrincess Margaret HospitalTorontoCanada